CJC-1295 / Ipamorelin (No DAC)

This preparation combines modified GRF (1-29), a GHRH fragment analog without a drug affinity complex, with ipamorelin, a synthetic pentapeptide that acts at the ghrelin receptor. It is supplied as a lyophilized mixture.

The two compound classes appear in the literature on pituitary signaling and growth hormone secretagogue receptor pharmacology in vitro and in animal models. No human-use conclusions are made here.

Supplied as a sterile lyophilized powder in a 3 mL vial. Reconstitute only with a suitable laboratory diluent such as bacteriostatic water, and record lot number and preparation date. Supplied for in vitro and laboratory research use only; not for human consumption or veterinary use.

Lyophilized powder. Store sealed at -20°C; stable at room temperature for shipping. After reconstitution refrigerate at 2-8°C.